NSN 6505-01-510-2359
Part Details | ISOSORBIDE MONONITRATE EXTENDED-RELEASE TABLETS
6505-01-510-2359
Alternate Parts: 031256, 03-1256, NDC62175012837, NDC62175-0128-37, NDC00603411021, NDC00603-4110-21, NDC00143223001, NDC00143-2230-01, 6505-01-510-2359, 01-510-2359, 6505015102359, 015102359
| Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
|---|---|---|---|
| 65 | JUL 16, 2003 | 01-510-2359 | 50449 ( ISOSORBIDE MONONITRATE EXTENDED-RELEASE TABLETS ) |
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-510-2359
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| 03-1256 | 89875 | DEFENSE LOGISTICS AGENCYDIRECTORATE OF MEDICAL MATERIEL |
| NDC62175-0128-37 | 3L8K2 | KREMERS URBAN LLCDBA SCHWARZ PHARMA MANUFACTURING |
| NDC00603-4110-21 | 0VZ14 | PAR PHARMACEUTICAL, INC.DBA PAR PHARMACEUTICAL |
| NDC00143-2230-01 | 32655 | WEST-WARD PHARMACEUTICALS CORP. |
Technical Data | NSN 6505-01-510-2359
| Characteristic | Specifications |
|---|---|
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | AB30.000 MILLIGRAMS ISOSORBIDE MONONITRATE |
| LONG ACTION METHOD | EXTENDED RELEASE |
| ADMINISTRATION | ORAL |
| COATING FEATURE | FILM, NONENTERIC |
| PRIMARY CONTAINER TYPE | BOTTLE, PLASTIC |
| PRIMARY CONTAINER CONTENT QUANTITY | 100.000 TABLETS |
| TOTAL PRIMARY CONTAINER QUANTITY | 1 |
| SUPPLEMENTARY FEATURES | CARDIOVASCULAR USE |
| SPECIAL FEATURES | EXTENDED RELEASE TABLETS, FOR THE PREVENTION OF ANGINA PECTORIS DUE TO CORONARY DISEASE; ONCE PER DAY DOSING; STORE AT ROOM TEMP.; PROTECT FROM EXCESSIVE MOISTURE |
| AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER | 241208 |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | ISOSORBIDE MONONITRATE EXTENDED RELEASE TABS 30MG 100S |
